Literature DB >> 8924349

Usefulness of the health belief model in predicting HIV needle risk practices among injection drug users.

R S Falck1, H A Siegal, J Wang, R G Carlson.   

Abstract

A health belief model (HBM) that included the dimensions of perceived susceptibility, seriousness, benefits, barriers, and self-efficacy was employed to predict which injection drug users (IDUs) were engaged in needle-use practices that reduced their risk for contracting the human immunodeficiency virus (HIV). A sample of 118 active IDUs, many of whom also used crack cocaine, responded to interviewer-administered questionnaires that gathered information on their drug-use practices in the last thirty days, as well as their health beliefs. Logistic regression analysis revealed that two health beliefs--perceived self-efficacy (OR = 1.27, 95% CI = 1.04, 1.55) and perceived susceptibility (OR = .82, 95% CI = .71, .94)--were significantly related to safer injection practices. Other predictors of safer injection were black ethnicity (OR = 3.18, 95% CI = 1.19, 8.47) and injection frequency (OR = .99, 95% CI = .98, .99). The results of this study suggest that the HBM has a role to play in risk-reduction programs targeting IDUs.

Entities:  

Mesh:

Year:  1995        PMID: 8924349

Source DB:  PubMed          Journal:  AIDS Educ Prev        ISSN: 0899-9546


  10 in total

1.  The influence of the perceived consequences of refusing to share injection equipment among injection drug users: balancing competing risks.

Authors:  Karla D Wagner; Stephen E Lankenau; Lawrence A Palinkas; Jean L Richardson; Chih-Ping Chou; Jennifer B Unger
Journal:  Addict Behav       Date:  2011-03-25       Impact factor: 3.913

2.  Perceived Severity of and Susceptibility to Overdose Among Injection Drug Users: Relationships With Overdose History.

Authors:  Erin E Bonar; Amy S B Bohnert
Journal:  Subst Use Misuse       Date:  2016-05-31       Impact factor: 2.164

3.  Accessing Medical Care After a Needlestick Injury: First Responders' Perception of HIV Risk and Attitudes Toward Syringe Service Programs.

Authors:  Gregory Carter; Carrie Lawrence; Brennan Woodward; Anita Ohmit
Journal:  J Community Health       Date:  2020-06

4.  Discriminatory attitudes towards people living with HIV/AIDS and associated factors: a population based study in the Chinese general population.

Authors:  J T F Lau; H Y Tsui
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

5.  Can drug users be effective change agents? Yes, but much still needs to change.

Authors:  Julia Dickson-Gomez
Journal:  Subst Use Misuse       Date:  2010       Impact factor: 2.164

Review 6.  Cognitive behavioral theories used to explain injection risk behavior among injection drug users: a review and suggestions for the integration of cognitive and environmental models.

Authors:  Karla Dawn Wagner; Jennifer B Unger; Ricky N Bluthenthal; Valentina A Andreeva; Mary Ann Pentz
Journal:  Health Educ Behav       Date:  2010-08

7.  Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest.

Authors:  J Rácz; V A Gyarmathy; A Neaigus; E Ujhelyi
Journal:  AIDS Care       Date:  2007-01

8.  News Attention and Social-Distancing Behavior Amid COVID-19: How Media Trust and Social Norms Moderate a Mediated Relationship.

Authors:  Xiaoya Jiang; Juwon Hwang; Dhavan V Shah; Shreenita Ghosh; Markus Brauer
Journal:  Health Commun       Date:  2021-01-13

9.  Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.

Authors:  Meghan D Morris; Erin Andrew; Judy Y Tan; Lisa Maher; Colleen Hoff; Lynae Darbes; Kimberly Page
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

10.  Effect of educational intervention on knowledge, perceived benefits, barriers and self-efficacy regarding AIDS preventive behaviors among drug addicts.

Authors:  Fatemeh Bastami; Firoozeh Mostafavi; Akbar Hassanzadeh
Journal:  J Educ Health Promot       Date:  2015-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.